3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Prostatic Neoplasms
18
Neoplasms
18
Breast Neoplasms
16
Colorectal Neoplasms
11
Carcinoma, Non-Small-Cell Lung
11
Lung Neoplasms
10
Urinary Bladder Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
6
Hematopoietic and Lymphatic System Neoplasm
6
Hematologic Neoplasms
6
Ovarian Neoplasms
5
Neoplasm Metastasis
5
Triple Negative Breast Neoplasms
4
Leukemia, Myeloid, Acute
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Pancreatic Neoplasms
3
Multiple Myeloma
3
Mouth Neoplasms
3
Hematopoietic and Lymphoid System Neoplasm
3
Head and Neck Neoplasms
3
Fallopian Tube Neoplasms
3
Carcinoma, Renal Cell
3
Sarcoma
2
Radiodermatitis
2
Peritoneal Neoplasms
2
Pathologic Complete Response
2
Parotid Neoplasms
2
Motor Activity
2
Melanoma
2
Malignant Solid Neoplasm
2
Interventions
pembrolizumab
4
Doxorubicin
3
Specimen Handling
2
spartalizumab
1
regorafenib
1
peposertib
1
liposomal doxorubicin
1
cabozantinib
1
X-Rays
1
Standard of Care
1
Quality of Life
1
Propranolol
1
Magnetic Resonance Spectroscopy
1
Injections
1
Ifosfamide
1
Histamine H2 Antagonists
1
Famotidine
1
Dactinomycin
1
Biopsy
1
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Histiocytoma, Malignant Fibrous
×
Standard of Care
×
Clear all
NCT04055220
2026-02-17
REGOSTA
Centre Leon Berard
Phase NA
Recruiting
168 enrolled